blood-brain barrier

The blood-brain barrier (BBB) is a tightly regulated interface between the bloodstream and the central nervous system. It is formed by specialised endothelial cells lining the brain's capillaries, reinforced by supporting cells called astrocytes and pericytes, whose combined architecture creates a selectively permeable seal around neural tissue.

Unlike capillaries elsewhere in the body, where small gaps allow relatively free molecular exchange, BBB endothelial cells are bound together by proteins called tight junctions. This structure lets the brain maintain a stable chemical environment — a prerequisite for reliable neural signalling — while blocking most pathogens and many potentially harmful compounds from entering.

How it works · its role

The barrier filters substances primarily by two properties: molecular size and lipophilicity (fat-solubility). Small, lipid-soluble molecules dissolve into the endothelial cell membranes and pass through with relative ease. Larger or water-soluble molecules are mostly excluded unless carried by specific transport proteins.

Active efflux transporters — most notably P-glycoprotein — add a further layer of restriction by recognising certain molecules that have crossed the membrane and pumping them back into the blood. Essential nutrients such as glucose and amino acids travel in the other direction via dedicated transporter proteins, ensuring the brain's metabolic needs are met without opening the barrier wholesale.

Relevance to substances & effects

A substance's ability to cross the BBB largely determines whether it produces any central effects at all. Most psychoactive drugs are lipophilic enough to cross readily, which is how they reach the brain in sufficient concentrations to alter mood, perception, or cognition.

Classic psychedelics, cannabinoids, opioids, and most sedative-hypnotics all share this lipophilic profile. The importance of BBB penetration is illustrated clearly by heroin (diacetylmorphine): the addition of two acetyl groups makes the molecule more lipophilic than morphine, allowing faster and more complete entry into the brain — a key reason its onset is more rapid and intense.

Some substances are deliberately engineered to cross poorly. Certain second-generation antihistamines, for instance, were reformulated to be less lipophilic than their predecessors, greatly reducing sedation as a side effect. In psychiatric medicine, achieving adequate brain concentrations without overloading peripheral systems is a routine challenge in drug development.